Artia Global Partners LP Axsome Therapeutics, Inc. Transaction History
Artia Global Partners LP
- $367 Billion
- Q3 2024
A detailed history of Artia Global Partners LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 87,848 shares of AXSM stock, worth $7.62 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
87,848
Previous 87,848
-0.0%
Holding current value
$7.62 Million
Previous $7.07 Billion
11.64%
% of portfolio
2.15%
Previous 1.37%
Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$363 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$286 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$205 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$90.7 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.72B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...